Spruce Biosciences SPRB
NASDAQ SPRB
$45.15 -0.85 (-1.85%)
At close: Oct 23, 2026 · 4:00 PM EDT

Spruce Biosciences (SPRB) Cash & Current Investments (2019 - 2026)

Updated

Spruce Biosciences (SPRB) reported Cash & Current Investments of $96.3 million for Q2 2026, up 487.6% from $16.39 million a year earlier and up 78.1% from the prior quarter.

Analysis

Spruce Biosciences (SPRB) Cash & Current Investments (2019 - 2026) Analysis & Trends

At the end of FY2025, Spruce Biosciences posted Cash & Current Investments of $48.91 million, up 26.2% from FY2024.

  • Cash & Current Investments has a five-year compound annual growth rate of -20.8% (FY2020 to FY2025).
  • By year, Cash & Current Investments came in at $38.75 million in FY2024 (-59.8%), $96.3 million in FY2023 (+21.7%), $79.1 million in FY2022 (-11.1%) and $88.97 million in FY2021 (-43.4%).
  • The Q2 2026 figure ranks as the highest quarterly Cash & Current Investments since Q4 2023.
  • Year over year, Cash & Current Investments has now increased in each of the last three quarters, with growth averaging 36.7% over the last eight quarters.
  • The high point for year-over-year Cash & Current Investments in five years was Q2 2026 (growth of 487.6%); the low point was Q3 2025 (a decline of 82.2%).
  • Per Business Quant data, the three quarters before Q2 2026 came in at $54.08 million (Q1 2026), $48.91 million (Q4 2025) and $10.67 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn 8.95 Bn
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn 17.23 Bn
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn 6.57 Bn
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn 7.14 Bn
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn 7.69 Bn
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn 4.90 Bn
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn 13.99 Bn
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn 3.18 Bn
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn 11.70 Bn
10 Spruce Biosciences 124.29 Mn -85.66 Mn - 96.30 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 96.30 Mn
Mar 31, 2026 54.08 Mn
Dec 31, 2025 48.91 Mn
Sep 30, 2025 10.67 Mn
Jun 30, 2025 16.39 Mn
Mar 31, 2025 25.62 Mn
Dec 31, 2024 38.75 Mn
Sep 30, 2024 60.06 Mn
Jun 30, 2024 69.68 Mn
Mar 31, 2024 81.15 Mn
Dec 31, 2023 96.30 Mn
Sep 30, 2023 108.00 Mn
Jun 30, 2023 120.50 Mn
Mar 31, 2023 118.60 Mn
Dec 31, 2022 79.10 Mn
Sep 30, 2022 90.40 Mn
Jun 30, 2022 93.30 Mn
Mar 31, 2022 91.35 Mn
Dec 31, 2021 88.97 Mn
Sep 30, 2021 92.32 Mn
API Access

Spruce Biosciences Cash & Current Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=SPRB&period=max&api_key=YOUR_API_KEY